An effective tumor vaccine optimized for costimulation via bispecific and trispecific fusion proteins

Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles

Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses

Second International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): Heidelberg, Germany, 10-12 October 2007

Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes

Host mediated anti-tumor effect of oncolytic Newcastle disease virus after locoregional application

Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy

Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus

In vitro induction of apoptosis in tumor cells by inactivated NDV and IAV

Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus